Image

Ashland: Poor Outcomes And Excessive Valuation (NYSE:ASH)

Blue Capsules on Conveyor at Modern Pharmaceutical Factory. Tablet and Capsule Manufacturing Process. Close-up Shot of Medical Drug Production Line.

SweetBunFactory

Ashland (NYSE:ASH) affords specialty components and components worldwide. ASH not too long ago introduced This fall FY23 and FY23 outcomes. They struggled in FY23 resulting from a destocking concern, which is predicted to have an effect on them in FY24. So, the outlook for FY24 isn’t that constructive, and its

SHARE THIS POST